Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06537999
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-31
Brief Title:
A Clinical Study to Evaluate DNTH103 in Adults with Multifocal Motor Neuropathy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 2 Randomized Double-Blinded Placebo-Controlled Study to Evaluate Safety Tolerability Pharmacometrics and Efficacy of DNTH103 in Adults with Multifocal Motor Neuropathy MOMENTUM
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MOMENTUM
Brief Summary:
The purpose of this Phase 2 study is to evaluate the safety tolerability pharmacometrics and efficacy of DNTH103 in participants with multifocal motor neuropathy MMN
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None